We are live on ! Find out more
NEPH icon

Nephros
NEPH

21 hedge funds and large institutions have $28.9M invested in Nephros in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 1

534% more capital invested

Capital invested by funds: $4.56M → $28.9M (+$24.4M)

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

62% more funds holding

Funds holding: 13 → 21 (+8)

42.84% more ownership

Funds ownership: 5.76% → 48.6% (+43%)

Holders
21
Holders Change
+8
Holders Change %
+61.54%
% of All Funds
0.46%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
10
Increased
5
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WC
Wexford Capital
Florida
+$28.8M
2
BA
Bard Associates
Illinois
+$1.76M
3
CPA
Cowen Prime Advisors
New York
+$1.31M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$482K
5
PHP
Parkman Healthcare Partners
Connecticut
+$438K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$21.1K
2
ISL
Ingalls & Snyder LLC
New York
-$11.9K
3
Deutsche Bank
Deutsche Bank
Germany
-$1K
4
UBS Group
UBS Group
Switzerland
-$934
Name Holding Trade Value Shares
Change 		Change in
Stake
WC
1
Wexford Capital
Florida
$21.4M +$28.8M +3,395,579 New
BA
2
Bard Associates
Illinois
$2.64M +$1.76M +207,569 New
PHP
3
Parkman Healthcare Partners
Connecticut
$1.58M +$438K +51,642 +26%
CPA
4
Cowen Prime Advisors
New York
$975K +$1.31M +154,800 New
ISL
5
Ingalls & Snyder LLC
New York
$839K -$11.9K -1,399 -1%
Vanguard Group
6
Vanguard Group
Pennsylvania
$357K +$482K +56,737 New
HighTower Advisors
7
HighTower Advisors
Illinois
$273K – – –
EIM
8
Essex Investment Management
Massachusetts
$251K +$338K +39,863 New
William Blair & Company
9
William Blair & Company
Illinois
$216K – – –
Millennium Management
10
Millennium Management
New York
$122K -$21.1K -2,489 -11%
BRWA
11
B. Riley Wealth Advisors
Florida
$91K +$1.48K +174 +1%
EP
12
Elkhorn Partners
Nebraska
$82K +$59.8K +7,049 +119%
BlackRock
13
BlackRock
New York
$54K +$51.8K +6,097 +238%
Morgan Stanley
14
Morgan Stanley
New York
$24K +$32.4K +3,815 New
UBS Group
15
UBS Group
Switzerland
$3K -$934 -110 -18%
SFS
16
Sowell Financial Services
Arkansas
$3K +$1.56K +184 +60%
PCM
17
Prelude Capital Management
New York
$2K – – –
TRCT
18
Tower Research Capital (TRC)
New York
$2K +$2.39K +282 New
CAN
19
Claraphi Advisory Network
United States
$2K +$3.29K +388 New
Osaic Holdings
20
Osaic Holdings
Arizona
$2K +$3.44K +405 New
Deutsche Bank
21
Deutsche Bank
Germany
– -$1K -200 Closed
Wells Fargo
22
Wells Fargo
California
– +$246 +29 New

NEPH Hedge Fund Activity: Q1 2020 in Review

21 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q1 2020, worth a combined $28.9M — up 534% from $4.56M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new NEPH positions and 1 closed out — a net gain of 9 holders — while 5 added to existing stakes and 3 trimmed.

The largest buyer was Wexford Capital, opening a new position worth an estimated $28.8M. The largest seller was Millennium Management, cutting an estimated $21.1K.

  • 21 institutional investors held Nephros (NEPH) as of Q1 2020, up from 13 in Q4 2019.
  • Funds reported $28.9M of Nephros stock for Q1 2020, up 534% quarter-over-quarter.
  • 10 funds opened new Nephros positions in Q1 2020 and 1 closed out, a net change of +9 holders.
  • The largest Nephros buyer in Q1 2020 was Wexford Capital, an estimated $28.8M added.
  • The largest Nephros seller in Q1 2020 was Millennium Management, an estimated $21.1K sold.

Based on aggregated 13F filings for Q1 2020.